| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 07/11/2001 | CN1303298A Gene therapy approaches to supply apolipoprotein A-1 agonists and their use to treat dyslipidemic disorders |
| 07/11/2001 | CN1303289A Adenosine A3 receptor modulators |
| 07/11/2001 | CN1303281A Use of compounds for elevation of pyruvate dehydrogenase activity |
| 07/11/2001 | CN1302811A Compound (I), extraction process and its application in preparing medicine to cure acute ischemic cerebrovascular disease |
| 07/11/2001 | CN1302808A Zinc fructose-diphosphate and its preparing process and application |
| 07/11/2001 | CN1302800A Method for preparing 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinoline |
| 07/11/2001 | CN1302663A Substrate tablet containing trimetazidine capable of long time controlled release after oral application |
| 07/11/2001 | CN1302635A Medical capsule for dredging channels and lowering blood pressure and its preparing process |
| 07/11/2001 | CN1302633A Chinese medicine containing spanishneedles herb and its preparing process |
| 07/11/2001 | CN1302629A Buccal lozenge of notoginseng flower |
| 07/11/2001 | CN1068327C 2,7-Substituted octahydro-1H-pyrido [1,2-alpha]pyrazin derivatives |
| 07/11/2001 | CN1068308C Substituted benzoylguanide, its preparing process and medicine and application of same |
| 07/11/2001 | CN1068222C Health-care tea and its preparing process |
| 07/11/2001 | CN1068207C Cap for preventing and curing cerebral hemorrhage |
| 07/11/2001 | CN1068203C Process for preparing medicinal liquor for treating heart disease |
| 07/10/2001 | US6258953 Arylacrylamide derivatives |
| 07/10/2001 | US6258951 Chemical compounds |
| 07/10/2001 | US6258850 3-aryl-2-hydroxypropionic acid derivative (I) |
| 07/10/2001 | US6258833 Enzyme inhibitors and antiinflammatory agents |
| 07/10/2001 | US6258824 Treatment of hyperproliferative diseases, such as cancers, in mammals. this invention also relates to a pharmaceutical compositions containing such compounds. |
| 07/10/2001 | US6258817 Substituted pyrazin-2-yl-sulphonamide (-3-pyridyl) compounds and uses thereof |
| 07/10/2001 | US6258805 Pyrroloazepine derivatives |
| 07/10/2001 | US6258800 Prodrugs of benzofuranylethyl carbamate NK1 antagonists |
| 07/10/2001 | US6258798 Method for treatment of unstable coronary artery disease by an early revascularisation together with administration of a low molecular weight heparin |
| 07/10/2001 | US6258793 Modifying cardiac activity, modifying adipocyte function, treating central nervous system disorders, and treating diabetic disorders and obesity in mammals |
| 07/10/2001 | US6258789 Delivery of gene products by intestinal cell expression |
| 07/10/2001 | US6258775 Bi-aromatic compounds, pharmaceutical and cosmetic compositions containing same and uses |
| 07/10/2001 | US6258584 Drug screening for modulators of collagen formation by measuring enzyme activity in presence and absence of compound; reduced activity indicates enzyme inhibitor; antiarthritic agents; antiscarring agents |
| 07/10/2001 | US6258580 Amino acid sequence of adaptor protein required for g protein-dependent activation of phosphatidylinositol-3-kinase; drug screening; diagnosis; antiarthritic agents; antiinflammatory agents; adult respiratory distress syndrome |
| 07/10/2001 | US6258562 Human antibodies that bind human TNFα |
| 07/10/2001 | US6258557 Nucleotide sequences associated with preferential gene expression; for the treatment of vascular injury; for reducing or preventing the development of arteriosclerosis |
| 07/10/2001 | US6258374 Rectal or vaginal administration; polymer stabilizer; water soluble foam structure |
| 07/10/2001 | CA2175643C Utilization of retinoids in a cosmetic composition or in the preparation of a pharmaceutical composition |
| 07/10/2001 | CA2175502C Cyclic amide derivatives |
| 07/10/2001 | CA2059792C Tricyclic compounds and intermediates thereof |
| 07/10/2001 | CA2017135C Substituted (quinolin-2-yl-methoxy)phenyl-acyl-sulphonamides and -cyanamides, processes for their preparation and their use in medicaments |
| 07/05/2001 | WO2001048231A2 Method of achieving persistent transgene expression |
| 07/05/2001 | WO2001048187A2 A molecular switch for regulating mammalian gene expression |
| 07/05/2001 | WO2001048153A1 Reconstructing organs from decellularized biomaterial scaffold |
| 07/05/2001 | WO2001048151A1 Cells capable of differentiating into heart muscle cells |
| 07/05/2001 | WO2001048014A1 Bh4-fused polypeptides |
| 07/05/2001 | WO2001047963A2 Inhibitors of complement activation, their preparation and use |
| 07/05/2001 | WO2001047960A1 Uses of transport proteins for controlling cell cycle |
| 07/05/2001 | WO2001047946A2 GFRα1-RET SPECIFIC AGONISTS AND METHODS THEREFOR |
| 07/05/2001 | WO2001047941A2 Benzophenone alpha-d-glycopyranosides, preparation and therapeutic use |
| 07/05/2001 | WO2001047940A1 Benzophenone glycopyranosides, preparation and therapeutic use |
| 07/05/2001 | WO2001047934A1 Isoxazolo pyrimidinones and the use thereof |
| 07/05/2001 | WO2001047930A1 Carboxamide diazepin derivatives, preparation method, use as medicines, pharmaceutical compositions and use thereof |
| 07/05/2001 | WO2001047929A1 Triazolotriazinones and the use thereof |
| 07/05/2001 | WO2001047928A2 Imidazo 1,3,5 triazinones and the use thereof |
| 07/05/2001 | WO2001047922A2 Azaindoles |
| 07/05/2001 | WO2001047921A1 Pyrimidine and triazine kinase inhibitors |
| 07/05/2001 | WO2001047920A1 Benzazole derivatives and their use as jnk modulators |
| 07/05/2001 | WO2001047919A1 Substituted oxazolidinones and their use in the field of blood coagulation |
| 07/05/2001 | WO2001047915A1 Cyclic amp-specific phosphodiesterase inhibitors |
| 07/05/2001 | WO2001047914A1 Cyclic amp-specific phosphodiesterase inhibitors |
| 07/05/2001 | WO2001047905A1 Pyrrolidine derivatives as cyclic amp-specific phosphodiesterase inhibitors |
| 07/05/2001 | WO2001047898A2 Substituted piperazine derivatives and their use as inhibitors of the microsomal triglyceride transfer protein (mtp) |
| 07/05/2001 | WO2001047897A1 Cytokine, especially tnf-alpha, inhibitors |
| 07/05/2001 | WO2001047893A1 New azabicyclooctane derivatives useful in the treatment of cardiac arrhythmias |
| 07/05/2001 | WO2001047892A1 Tricyclic protein kinase inhibitors |
| 07/05/2001 | WO2001047891A1 Heterocyclic compounds having sulfonamide groups |
| 07/05/2001 | WO2001047890A1 Quinoline and quinazoline derivatives and drugs containing the same |
| 07/05/2001 | WO2001047887A1 β-AMINO ACID COMPOUNDS AS INTEGRIN ANTAGONISTS |
| 07/05/2001 | WO2001047886A1 Nitrile derivatives as cathepsin k inhibitors |
| 07/05/2001 | WO2001047885A1 Substituted indole mannich bases |
| 07/05/2001 | WO2001047880A1 Cyclic amp-specific phosphodiesterase inhibitors |
| 07/05/2001 | WO2001047879A1 Pyrrolidines which inhibit camp-specific pde |
| 07/05/2001 | WO2001047878A1 Substituted pyrrole mannich bases to combat pain and allergic reactions |
| 07/05/2001 | WO2001047874A1 (hetero)bicyclymethanesulfonylamino-substituted hydroxamic acid derivatives |
| 07/05/2001 | WO2001047866A1 Substituted 1 and 2 naphthol mannich bases |
| 07/05/2001 | WO2001047859A1 Compounds active at the glucocorticoid receptor |
| 07/05/2001 | WO2001047562A2 Hydrolytically degradable carbamate derivatives of poly(ethylene glycol) |
| 07/05/2001 | WO2001047558A1 Nerve protective drugs |
| 07/05/2001 | WO2001047533A2 INHIBITION OF GSK-3$g(b) |
| 07/05/2001 | WO2001047514A1 Use of hypoglycemic agent for treating impaired glucose metabolism |
| 07/05/2001 | WO2001047509A2 Composition for the treatment diabetes mellitus containing an insuline sensitizer and agent used in the treatment of cardiac conditions |
| 07/05/2001 | WO2001047507A2 Combinations of receptor tyrosine kinase inhibitor with an a1-acidic glycoprotein binding compound |
| 07/05/2001 | WO2001047506A2 Use of substituted 4-amino-1-phenylbutan-2-ol compounds as medicaments |
| 07/05/2001 | WO2001047494A1 Method for co-grinding substances and lactose by means of jet mils |
| 07/05/2001 | WO2001047451A1 Apparatus and method for delivering compounds to a living organism |
| 07/05/2001 | WO2001012592A3 Hydroxamic acid compounds useful as matrix metalloproteinase inhibitors |
| 07/05/2001 | WO2001003720A9 Promotion or inhibition of angiogenesis and cardiovascularization by tumor necrosis factor ligand/receptor homologs |
| 07/05/2001 | WO2001002363A3 N-substituted glycine derivatives |
| 07/05/2001 | WO2000078332A3 Fish serine proteinases and their pharmaceutical and cosmetic use |
| 07/05/2001 | WO2000073278A3 5-phenyl-pyrimidine derivatives |
| 07/05/2001 | WO2000070046A3 Secreted polypeptides and corresponding polynucleotides |
| 07/05/2001 | WO2000066138A3 Metabolic intervention with glp-1 to improve the function of ischemic and reperfused tissue |
| 07/05/2001 | WO2000061622A3 Genes associated with diseases of the kidney |
| 07/05/2001 | WO2000059942A3 Human obesity protein binding protrein-2 homolog and uses thereof |
| 07/05/2001 | WO2000055137A8 Compounds and methods for modulation of estrogen receptors |
| 07/05/2001 | WO2000040247A8 2-oxy-benzoxazinone derivatives for the treatment of obesity |
| 07/05/2001 | WO2000023114A9 Polymer conjugates of interferon beta- 1a and their uses |
| 07/05/2001 | WO2000018799A9 Artemin, a novel neurotrophic factor |
| 07/05/2001 | WO1999053910A8 Folic acid-containing pharmaceutical compositions, and related methods and delivery systems |
| 07/05/2001 | US20010007020 Antibodies that bind to the nidogen-binding domain of laminin, their production and use |
| 07/05/2001 | US20010006971 Administering an antiallergen of loratadine or metabolite of loratadine, desloratadine; migraines, stroke, orthostatic hypotension, gastrointestinal stasis, nausea, dizziness and jet lag; also psychological disorders; 5-HT7 receptors |
| 07/05/2001 | US20010006954 Synthetic DNA comprising a radiation responsive enhancer-promoter operatively linked to a polypeptide encoding region linked to a transcription terminating region; regulating gene expression and inhibiting tumor growth |
| 07/05/2001 | US20010006940 Human chorionic gonadotrophin (hCG) used to treat or prevent tumors, multiple sclerosis, inflammation or angiogenesis-dependent diseases |
| 07/05/2001 | US20010006640 Compounds and methods to inhibit or augment an inflammatory response |